CA Patent

CA2384188C — Antiviral compositions

Assigned to Janssen Pharmaceutica NV · Expires 2008-06-17 · 18y expired

What this patent protects

The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be admin-istered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one …

USPTO Abstract

The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be admin-istered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

Drugs covered by this patent

Patent Metadata

Patent number
CA2384188C
Jurisdiction
CA
Classification
—
Expires
2008-06-17
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.